insights

Katherine Leibowitz Presenting on AI’s Impact on CTA Terms – October 21st and 24th at MAGI@home Fall 2025 Clinical Research Conference

It’s back-to-school season and time to sharpen your skills at the week-long MAGI@home Clinical Research Conference!  We’re excited to share that Katherine Leibowitz will present on how clinical trial agreement (CTA) terms should evolve to address the use of artificial intelligence (AI) in clinical trial administration.

Join Katherine and co-speaker Emily Njus as they explore how tools like ChatGPT are influencing CTA drafting and negotiation practices. The session will highlight emerging stakeholder concerns, practical strategies for addressing them, and a look ahead at the next generation of AI-related contract clauses.

Think you can Stump the Experts?

Join Katherine again on Friday for the CTA Stump the Experts panel, where she and Theresa Latham will answer your toughest questions about drafting and negotiating clinical trial agreements.

The virtual MAGI@home Clinical Research Conference runs October 20-24, 2025, so you can participate from the comfort of your home or office.

  • AI’s Impact on CTA Terms — October 21, 11:30 a.m.–12:30 p.m. ET
  • CTA Stump the Experts — October 24, 11:30 a.m.–12:30 p.m. ET

The MAGI conferences are a great way to stay current on what’s happening in clinical research across sites, sponsors and CROs.  You can view the full program agenda and register for the conference here.

This contents of this alert should not be construed as legal advice or a legal opinion on any specific facts or circumstances. This content is not intended to and does not, by its receipt, create an attorney-client relationship. The contents are intended for general informational purposes only. We urge you to consult your attorney about the specific situation and any legal questions you may have. Attorney advertising in some jurisdictions. © 2025 Leibowitz Law. All rights reserved. “Leibowitz Law” is a trade name of Leibowitz LLC.

Want to receive notifications?

To be notified when we post new Insights, please sign up for our email list. As industry thought leaders, Leibowitz Law Insights address developing issues at the intersection of law, regulation, technology and life sciences…

SIGN UP FOR OUR LATEST INSIGHTS